Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

BIOD Insider Trading

BIOD | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at BIOD provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2008-06-23 21:00 2008-06-20 WEISMAN SCOTT Director SELL $14.82 8,199 $121,471 414,937 -1.9%
2008-05-23 22:29 2008-05-21 WEISMAN SCOTT Director SELL $16.05 10,000 $160,464 423,136 -2.3%
2008-02-16 01:08 2008-02-12 KROIN DAVID Director SELL $15.50 154,000 $2,387,000 1,812,574 -7.8%
2008-02-15 17:40 2008-02-12 STEINER VENTURES LLC 10% owner SELL $15.50 92,441 $1,432,836 4,044,266 -2.2%
2008-02-15 05:42 2008-02-12 CHA ALBERT Director SELL $15.50 132,000 $2,046,000 1,553,632 -7.8%
2008-02-15 05:37 2008-02-12 Wertheimer Samuel P Director SELL $15.50 154,000 $2,387,000 1,812,892 -7.8%
2008-02-15 05:23 2008-02-12 Pereira Brian JG Director BUY $15.50 30,000 $465,000 30,000 +100.0%
2008-02-15 05:11 2008-02-12 Steiner Solomon Director, Officer, 10% owner - President & CEO SELL $15.50 110,000 $1,705,000 4,044,266 -2.6%
2008-02-15 02:59 2008-02-12 ORBIMED ADVISORS LLC Director, 10% owner SELL $14.48 154,000 $2,229,920 1,812,892 -7.8%
2008-02-06 00:06 2008-02-01 Steiner Solomon Director, Officer, 10% owner - President & CEO SELL $17.42 1,407 $24,505 85,192 -1.6%
2008-02-02 00:11 2008-01-30 POHL RODERIKE Officer - VP Research SELL $17.64 2,262 $39,894 154,709 -1.4%
2008-02-02 00:10 2008-01-30 POHL RODERIKE Officer - VP Research SELL $17.83 2,339 $41,705 156,971 -1.5%
2008-02-01 01:09 2008-01-29 POHL RODERIKE Officer - VP Research SELL $18.00 2,000 $35,999 159,310 -1.2%
2008-01-31 17:56 2008-01-28 POHL RODERIKE Officer - VP Research SELL $17.60 1,149 $20,217 161,710 -0.7%
2008-01-30 23:14 2008-01-28 POHL RODERIKE Officer - VP Research SELL $17.60 1,149 $20,217 161,310 -0.7%
2008-01-28 23:29 2008-01-24 POHL RODERIKE Officer - VP Research SELL $18.11 2,992 $54,191 162,459 -1.8%
2008-01-25 00:29 2008-01-22 POHL RODERIKE Officer - VP Research SELL $18.64 3,258 $60,728 162,193 -2.0%
2008-01-23 00:53 2008-01-18 POHL RODERIKE Officer - VP Research SELL $18.19 1,200 $21,831 165,451 -0.7%
2008-01-23 00:52 2008-01-18 POHL RODERIKE Officer - VP Research SELL $18.63 4,800 $89,412 166,651 -2.8%
2008-01-23 00:51 2008-01-17 POHL RODERIKE Officer - VP Research SELL $21.35 1,600 $34,160 171,451 -0.9%
2008-01-19 00:13 2008-01-16 POHL RODERIKE Officer - VP Research SELL $22.23 3,650 $81,141 173,051 -2.1%
2008-01-17 23:59 2008-01-15 POHL RODERIKE Officer - VP Research SELL $23.51 2,850 $67,014 176,701 -1.6%
2008-01-17 23:36 2008-01-15 WEISMAN SCOTT Director SELL $23.40 5,000 $117,000 433,136 -1.1%
2008-01-17 01:06 2008-01-14 POHL RODERIKE Officer - VP Research SELL $23.24 9,650 $224,312 179,552 -5.1%
2008-01-11 00:39 2008-01-08 POHL RODERIKE Officer - VP Research SELL $23.45 5,416 $127,011 189,202 -2.8%
2008-01-10 03:07 2008-01-04 WARE R TIMMIS Officer - Corp. Secy and General Counsel SELL $25.12 9,630 $241,895 65,603 -12.8%
2008-01-10 03:06 2008-01-04 WARE R TIMMIS Officer - Corp. Secy and General Counsel SELL $23.61 11,300 $266,835 75,233 -13.1%
2008-01-10 03:06 2008-01-04 WARE R TIMMIS Officer - Corp. Secy and General Counsel SELL $24.23 10,400 $251,942 86,533 -10.7%
2008-01-08 01:29 2008-01-03 WARE R TIMMIS Officer - Corp. Secy and General Counsel SELL $22.74 3,700 $84,146 106,733 -3.4%
2008-01-08 01:27 2008-01-03 WARE R TIMMIS Officer - Corp. Secy and General Counsel SELL $22.99 9,800 $225,325 96,933 -9.2%
2008-01-04 23:50 2008-01-02 Steiner Solomon Director, Officer, 10% owner - President & CEO SELL $23.22 18,999 $441,229 4,136,707 -0.5%
2008-01-04 23:49 2008-01-02 Steiner Solomon Director, Officer, 10% owner - President & CEO SELL $22.93 9,106 $208,771 4,136,707 -0.2%
2007-12-28 22:31 2007-12-27 POHL RODERIKE Officer - VP Research SELL $23.24 2,850 $66,234 194,618 -1.4%
2007-12-28 03:22 2007-12-26 POHL RODERIKE Officer - VP RESEARCH SELL $22.88 7,063 $161,584 197,468 -3.5%
2007-12-28 03:21 2007-12-21 POHL RODERIKE Officer - VP RESEARCH SELL $22.01 5,087 $111,954 204,531 -2.4%
2007-12-20 01:46 2007-12-17 WEISMAN SCOTT Director SELL $19.63 5,000 $98,150 438,136 -1.1%
2007-12-20 01:01 2007-12-18 POHL RODERIKE Officer - VP Research SELL $20.13 10,000 $201,284 209,618 -4.6%
2007-12-20 01:00 2007-12-17 Steiner Solomon Director, Officer, 10% owner - President & CEO SELL $19.97 12,155 $242,737 114,904 -9.6%
2007-12-20 00:59 2007-12-18 Steiner Solomon Director, Officer, 10% owner - President & CEO SELL $19.67 200 $3,934 114,704 -0.2%
2007-12-19 05:49 2007-12-17 Steiner Solomon Director, Officer, 10% owner - President & CEO SELL $19.55 600 $11,727 127,059 -0.5%
2007-12-19 05:48 2007-12-14 Steiner Solomon Director, Officer, 10% owner - President & CEO SELL $19.68 19,900 $391,626 127,659 -13.5%
2007-12-19 04:09 2007-12-14 POHL RODERIKE Officer - VP Research SELL $19.67 10,000 $196,670 219,618 -4.4%
2007-12-05 01:23 2007-11-30 LIEBERMAN IRA Director SELL $17.50 21,535 $376,863 0 -100.0%
2007-12-05 00:17 2007-11-30 POHL RODERIKE Officer - VP Research SELL $18.11 4,480 $81,111 229,168 -1.9%
2007-11-29 23:05 2007-11-27 POHL RODERIKE Officer - VP Research SELL $18.00 520 $9,360 233,648 -0.2%
2007-11-27 01:41 2007-11-21 POHL RODERIKE Officer - VP Research SELL $17.00 10,000 $170,000 234,168 -4.1%
2007-06-27 01:07 2007-05-16 REDING F SCOTT Officer - Chief Financial Officer BUY $15.00 4,730 $70,950 3,290 +100.0%
SHOW ENTRIES
101-147 OF 147

How to Interpret $BIOD Trades

Not every insider transaction in BIOD is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $BIOD shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for BIOD

Insider activity data for BIOD is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $BIOD, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.